Outcome of Board Meeting

Pat Growth 25pctExceptional ItemResults View source PDF

SHALBY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.6%1-day move

₹170.00

prior close

₹176.46

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-3.7-3.4-3.6-0.6+4.1+3.0+2.5+2.9+0.1+0.0+0.6——

Up moveDown movePending

AI summary

Shalby Limited reported audited standalone FY2026 revenue of ₹8,985.58 million (up 3.4% YoY) and PAT of ₹1,129.10 million (up 34.8% YoY) with EPS of ₹10.50. Consolidated revenue stood at ₹11,414.29 million with PAT of ₹346.87 million, significantly improved from ₹19.20 million in FY25. The auditors issued an unmodified (clean) opinion on the results. The Board did not recommend any dividend for FY2025-26. One-time tax impact of ₹340.16 million was recognized due to adoption of new tax regime under Section 115BAA, along with MAT credit write-off of ₹42.36 million. An exceptional item of ₹6.96 million was recorded as impairment of investment in subsidiary Yogeshwar Healthcare Limited.

Likely market impact

Strong standalone profitability with 34.8% PAT growth is positive, though the wide gap between standalone (PAT ₹1,129M) and consolidated PAT (₹347M) highlights significant losses in subsidiaries weighing on group performance. No dividend may disappoint income-focused investors.